Literature DB >> 20857098

FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position.

Irene A Burger1, David A Scheiner, David W Crook, Valerie Treyer, Thomas F Hany, Gustav K von Schulthess.   

Abstract

PURPOSE: The aim of the study was to determine the aetiology of FDG uptake in vaginal tampons (VT), a known artefact in premenopausal women evaluated by PET/CT.
METHODS: This Institutional Review Board approved study consisted of retrospective and prospective parts. The retrospective analysis included 685 women examined between January 2008 and December 2009 regarding VT presence. PET/CT images were analysed to determine the localization and the standardized uptake value (SUV) of VTs. We prospectively recruited 24 women (20-48 years old) referred for staging or follow-up in an oncology setting between February and April 2010, who were provided a commercial VT to be used during the entire examination after obtaining written informed consent. After image acquisition, VTs were individually analysed for creatinine concentration and blood traces. Statistical significance was tested with the Mann-Whitney U test.
RESULTS: In the retrospective part, 38 of 685 women were found to have a VT of which 17 (45%) were FDG positive. A statistically significant correlation was found between FDG activity and VT position below the pubococcygeal line (PCL) (13 ± 11.2 mm). In the prospective study, 7 of 24 (29%) women had increased FDG activity in their VTs (SUV 18.8 ± 11 g/ml) but were not menstruating. FDG-positive VTs were significantly lower in position (14.6 ± 11.4 mm,below the PCL) than FDG-negative VTs (p = 0.039). The creatinine concentration was significantly increased in all seven positive VTs (931 ± 615 μmol/l).
CONCLUSION: FDG uptake in VTs is caused by urine contamination, which is likely related to localization below the PCL resulting in contact with urine during voiding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20857098     DOI: 10.1007/s00259-010-1618-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  15 in total

1.  Artifact on PET/CT secondary to FDG accumulation in a vaginal tampon.

Authors:  Eric J Heffernan; Stephen J Skehan
Journal:  Clin Nucl Med       Date:  2007-03       Impact factor: 7.794

2.  MR imaging of the pelvis.

Authors:  J P Heiken; J K Lee
Journal:  Radiology       Date:  1988-01       Impact factor: 11.105

3.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

Authors:  Ursula Nestle; Stephanie Kremp; Andrea Schaefer-Schuler; Christiane Sebastian-Welsch; Dirk Hellwig; Christian Rübe; Carl-Martin Kirsch
Journal:  J Nucl Med       Date:  2005-08       Impact factor: 10.057

4.  Estimation of creatinine by the Jaffe reaction. A comparison of three methods.

Authors:  H Husdan; A Rapoport
Journal:  Clin Chem       Date:  1968-03       Impact factor: 8.327

5.  Glucose in vaginal secretions before and after oral glucose tolerance testing in women with and without recurrent vulvovaginal candidiasis.

Authors:  Sophia Ehrström; Anna Yu; Eva Rylander
Journal:  Obstet Gynecol       Date:  2006-12       Impact factor: 7.661

Review 6.  MR imaging of the female pelvic region.

Authors:  M C Olson; H V Posniak; C M Tempany; C M Dudiak
Journal:  Radiographics       Date:  1992-05       Impact factor: 5.333

7.  Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies.

Authors:  Ehab M Kamel; Patrice Jichlinski; John O Prior; Jean-Yves Meuwly; Jean-Francois Delaloye; Laurent Vaucher; Jerome Malterre; Sandra Castaldo; Hans-Juerg Leisinger; Angelika Bischof Delaloye
Journal:  J Nucl Med       Date:  2006-11       Impact factor: 10.057

8.  Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.

Authors:  Hedva Lerman; Ur Metser; Dan Grisaru; Ami Fishman; Gennady Lievshitz; Einat Even-Sapir
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

9.  Stage IB cervical carcinoma: comparison of clinical, MR, and pathologic staging.

Authors:  D Rubens; J R Thornbury; C Angel; M H Stoler; S L Weiss; R M Lerner; J Beecham
Journal:  AJR Am J Roentgenol       Date:  1988-01       Impact factor: 3.959

10.  A study of the liver-heart artifact in emission tomography.

Authors:  J Nuyts; P Dupont; V Van den Maegdenbergh; S Vleugels; P Suetens; L Mortelmans
Journal:  J Nucl Med       Date:  1995-01       Impact factor: 10.057

View more
  1 in total

Review 1.  The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT.

Authors:  David Dudoignon; David A Pattison; Damien Legallois; Rodney J Hicks; Nicolas Aide
Journal:  Cancer Imaging       Date:  2020-09-22       Impact factor: 3.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.